MET
NEUTRAL
$71.31
Live
MetLife, Inc. · NYSE
Target $90.5
(+26.9%)
$65.21
52W Range
$83.85
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 01, 2026
Market cap
$46.99B
P/E
15.14
ROE
12.0%
Profit margin
4.4%
Debt/Equity
2.26
Dividend yield
3.21%
AI Analysis
AI-powered fundamental assessment
Confidence
85%
MET shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.
Key Strengths
Strong revenue growth of 27.6%
Key Risks
Low profit margin of 4.4%
High debt burden with D/E of 2.26
AI Fair Value Estimate
Based on comprehensive analysis
$32.97
-53.8% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
49
Moderate
50
65
40
40
50
AI Verdict
MET shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.
Key drivers: Strong revenue growth of 27.6%, Low profit margin of 4.4%, High debt burden with D/E of 2.26
Confidence
45%
Value
50/100
Rule-based valuation (P/E + Graham).
Positives
- Insufficient data for clear positives.
Watchpoints
- Trades above Graham Number.
Future
65/100
Rule-based growth outlook.
Positives
- Revenue growth running at 27.6%.
Watchpoints
No urgent risks highlighted.
Past
40/100
Historical performance + price trend: Shares moved +34.8% over 5Y and -9.5% over 1Y.
Positives
- Insufficient data for clear positives.
Watchpoints
- Thin profit margins.
Health
40/100
Balance sheet & liquidity (Z-Score: N/A).
Positives
- Insufficient data for clear positives.
Watchpoints
- High D/E ratio (2.26).
Dividend
50/100
Dividend policy fallback.
Positives
- Moderate dividend profile (Score: 50/100).
- Yield: 3.2%.
Watchpoints
No urgent risks highlighted.
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$71.31
Analyst Target
$90.5
Upside/Downside
+26.9%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for MET and closest competitors.
Updated 2026-04-01
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
MET
MetLife, Inc.
Primary
|
+34.8% | +35.0% | -9.5% | -11.7% | -2.6% | +1.3% |
|
COIN
Coinbase Global, Inc.
Peer
|
-46.8% | +158.4% | +1.4% | -48.3% | -5.7% | -3.5% |
|
AMP
Ameriprise Financial, Inc.
Peer
|
+153.4% | +52.0% | -10.7% | -4.1% | -0.9% | -2.5% |
|
NDAQ
Nasdaq, Inc.
Peer
|
+70.7% | +59.2% | +20.3% | -0.6% | -0.0% | -2.5% |
|
MSCI
MSCI Inc.
Peer
|
+49.6% | +16.3% | -5.3% | -0.6% | +3.2% | -2.7% |
MET
MetLife, Inc.
Primary
5Y
+34.8%
3Y
+35.0%
1Y
-9.5%
6M
-11.7%
1M
-2.6%
1W
+1.3%
COI
Coinbase Global, Inc.
Peer
5Y
-46.8%
3Y
+158.4%
1Y
+1.4%
6M
-48.3%
1M
-5.7%
1W
-3.5%
AMP
Ameriprise Financial, Inc.
Peer
5Y
+153.4%
3Y
+52.0%
1Y
-10.7%
6M
-4.1%
1M
-0.9%
1W
-2.5%
NDA
Nasdaq, Inc.
Peer
5Y
+70.7%
3Y
+59.2%
1Y
+20.3%
6M
-0.6%
1M
-0.0%
1W
-2.5%
MSC
MSCI Inc.
Peer
5Y
+49.6%
3Y
+16.3%
1Y
-5.3%
6M
-0.6%
1M
+3.2%
1W
-2.7%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
15.14
Forward P/E
6.52
PEG Ratio
N/A
P/B Ratio
1.65
P/S Ratio
0.61
EV/Revenue
1.12
EV/EBITDA
14.48
Market Cap
$46.99B
Profitability
Profit margins and return metrics
Profit Margin
4.38%
Operating Margin
4.67%
Gross Margin
23.36%
ROE
12.02%
ROA
0.46%
Growth
Revenue and earnings growth rates
Revenue Growth
+27.6%
Earnings Growth
-34.2%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
-36.3%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
2.26
High debt
Current Ratio
1.9
Good
Quick Ratio
1.59
Excellent
Cash/Share
$39.31
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$23.3B
Net Margin
3.5%
Total Assets
$745.2B
Liabilities
$716.2B
Equity
$28.4B
Debt/Equity
25.22x
Operating CF
$7.1B
Free Cash Flow
$7.1B
FCF Yield
100%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-04-29
$N/A
2026-02-04
$2.49
+6.3% surprise
2025-11-05
$2.37
+2.2% surprise
2025-08-06
$2.02
-6.7% surprise
Financial Services Sector Comparison
Comparing MET against 820 companies in the Financial Services sector
(141 bullish, 351 neutral, 328 bearish)
P/E Ratio
15.14
This Stock
vs
36.01
Sector Avg
-58.0%
(Discount)
Return on Equity (ROE)
12.02%
This Stock
vs
-0.73%
Sector Avg
-1740.4%
(Below Avg)
Profit Margin
4.38%
This Stock
vs
91.62%
Sector Avg
-95.2%
(Weaker)
Debt to Equity
2.26
This Stock
vs
1.36
Sector Avg
+66.3%
(Higher)
Revenue Growth
27.6%
This Stock
vs
35.27%
Sector Avg
-21.7%
(Slower)
Current Ratio
1.9
This Stock
vs
3.18
Sector Avg
-40.4%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
MET
MetLife, Inc.
|
NEUTRAL | $46.99B | 15.14 | 12.0% | 4.4% | $71.31 | |
|
COIN
Coinbase Global, Inc.
|
BEARISH | $47.08B | 39.24 | 10.1% | 18.3% | $174.61 | Compare |
|
AMP
Ameriprise Financial, Inc.
|
NEUTRAL | $46.82B | 13.98 | 59.6% | 19.6% | $496.6 | Compare |
|
NDAQ
Nasdaq, Inc.
|
NEUTRAL | $49.32B | 27.95 | 15.3% | 34.1% | $86.37 | Compare |
|
MSCI
MSCI Inc.
|
BULLISH | $43.08B | 35.84 | -% | 40.0% | $565.15 | Compare |
MET
MetLife, Inc.
NEUTRAL
Mkt Cap
$47.0B
P/E
15.1
ROE
12.0%
Price
$71.31
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | HARRIS CARLA A | Director | Stock Award | 43 | $3,036 |
| 2026-03-10 | JOHNSON JEH CHARLES | Director | Stock Award | 65 | $4,589 |
| 2026-03-10 | KENNARD WILLIAM E | Director | Stock Award | 365 | $25,769 |
| 2026-03-10 | HUBBARD ROBERT GLENN | Director | Stock Award | 771 | $54,433 |
| 2026-03-10 | MUMENTHALER CHRISTIAN STEPHANE | Director | Stock Award | 17 | $1,200 |
| 2026-03-10 | HAY LAURA J | Director | Stock Award | 40 | $2,824 |
| 2026-03-10 | MCKENZIE DIANA L | Director | Stock Award | 189 | $13,343 |
| 2026-02-24 | MCCALLION JOHN D. CPA | Chief Financial Officer | Stock Award | 50,826 | - |
| 2026-02-24 | TADROS RAMY | Officer | Stock Award | 42,916 | - |
| 2026-02-24 | GLASER DANIEL S | Director | Stock Award | 273 | $20,568 |
| 2026-02-24 | GLASER DANIEL S | Director | Stock Award | 273 | $20,568 |
| 2026-02-24 | KHALAF MICHEL | Chief Executive Officer | Stock Award | 150,650 | - |
| 2026-02-24 | O'NEILL ADRIENNE KAREN | Officer | Stock Award | 2,655 | - |
| 2026-02-24 | PAPPAS BILL | Officer | Stock Award | 43,374 | - |
| 2026-02-24 | SEITZ MICHELLE | Director | Stock Award | 273 | - |
HARRIS CARLA A
Director
2026-03-10
43 shares
·
$3,036
JOHNSON JEH CHARLES
Director
2026-03-10
65 shares
·
$4,589
KENNARD WILLIAM E
Director
2026-03-10
365 shares
·
$25,769
HUBBARD ROBERT GLENN
Director
2026-03-10
771 shares
·
$54,433
MUMENTHALER CHRISTIAN STEPHANE
Director
2026-03-10
17 shares
·
$1,200
HAY LAURA J
Director
2026-03-10
40 shares
·
$2,824
MCKENZIE DIANA L
Director
2026-03-10
189 shares
·
$13,343
MCCALLION JOHN D. CPA
Chief Financial Officer
2026-02-24
50,826 shares
TADROS RAMY
Officer
2026-02-24
42,916 shares
GLASER DANIEL S
Director
2026-02-24
273 shares
·
$20,568
GLASER DANIEL S
Director
2026-02-24
273 shares
·
$20,568
KHALAF MICHEL
Chief Executive Officer
2026-02-24
150,650 shares
O'NEILL ADRIENNE KAREN
Officer
2026-02-24
2,655 shares
PAPPAS BILL
Officer
2026-02-24
43,374 shares
SEITZ MICHELLE
Director
2026-02-24
273 shares
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
16 analysts
TD Cowen
2026-03-11
Buy
Buy
Morgan Stanley
2026-03-03
Overweight
Overweight
Wells Fargo
2026-02-25
Overweight
Overweight
Evercore ISI Group
2026-02-11
In-Line
In-Line
UBS
2026-02-05
Buy
Buy
Wells Fargo
2026-01-13
Overweight
Overweight
UBS
2026-01-08
Buy
Buy
Wells Fargo
2025-12-23
Overweight
Overweight
Mizuho
2025-12-16
Outperform
Keefe, Bruyette & Woods
2025-11-11
Outperform
Outperform
Past News Coverage
Recent headlines mentioning MET from our newsroom.
Newest → oldest
No matching news yet.